Basic Information
Basic information for SNHG17-254-29aa
Peptide Name SNHG17-254-29aa
Genome Position chr20:38421006-38421043,38422193-38422241[-]
Species Human
Peptide Sequence MLSVAVAEEEPPEICVGLSLRSKDSPRKS
Peptide Length 29
Unique No (SNHG17-211-29aa-2,SNHG17-214-29aa,SNHG17-216-29aa-2,SNHG17-218-29aa,SNHG17-219-29aa,SNHG17-225-29aa,SNHG17-228-29aa,SNHG17-236-29aa,SNHG17-239-29aa,SNHG17-242-29aa,SNHG17-244-29aa,SNHG17-261-29aa-2,SNHG17-266-29aa,SNHG17-268-29aa,SNHG17-273-29aa,SNHG17-276-29aa-2,SNHG17-277-29aa,SNHG17-281-29aa,SNHG17-286-29aa)
Grand Average of Hydropathicity -0.2414
Relative Molecular Mass 3632.99
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000196756;SNHG17
Transcript ID/Name ENST00000663540;SNHG17-254
Transcript Length 1021
Coding Ability 0.3761
DNA Sequence Corresponding to Peptide ATGCTTTCAGTGGCTGTTGCAGAGGAAGAGCCTCCGGAAATCTGCGTGGGTCTCAGCCTTAGATCCAAGGACAGTCCAAGGAAGTCC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :